Inflammatory bowel disease among Bedouin Arabs in southern Israel: Urbanization and increasing prevalence rates

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 3, 2015, Pages 230-234

  Abu Freha, Naim ^a   Schwartz, Doron ^a   Elkrinawi, Jaber ^a   Ben Yakov, Gil ^a   Abu Tailakh, Muhammad ^a   Munteanu, Daniela ^a   Abu Ganim, Abdelrhman ^a   Fich, Alexander ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

anti TNF ; Bedouin population; inflammatory bowel disease; prevalence; southern Israel

Indexed keywords

IMMUNOMODULATING AGENT; MESALAZINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; GASTROINTESTINAL AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BEDOUIN; CITY; CLINICAL FEATURE; COHORT ANALYSIS; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; ILEUM DISEASE; INCIDENCE; INFLAMMATORY BOWEL DISEASE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MONTREAL CLASSIFICATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RURAL AREA; TOTAL COLON RESECTION; ULCERATIVE COLITIS; URBANIZATION; AGED; ANTAGONISTS AND INHIBITORS; ARAB; COLITIS, ULCERATIVE; DEMOGRAPHY; EPIDEMIOLOGY; ETHNOLOGY; HEALTH; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TRENDS;

ADULT; AGED; ARABS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; ISRAEL; MALE; MIDDLE AGED; PREVALENCE; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; URBAN HEALTH; URBANIZATION;

EID: 84922403062     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000263     Document Type: Article

References (24)

1. Zvidi I, Fraser GM, Niv Y, Birkenfeld S. The prevalence of inflammatory bowel disease in an Israeli Arab population. J Crohns Colitis 2013; 7:e159-e163.
2. Odes HS, Fraser D, Krawiec J. Incidence of idiopathic ulcerative colitis in Jewish population subgroups in the Beer Sheva region of Israel. Am J Gastroenterol 1987; 82:854-858.
3. Shapira M, Tamir A. Ulcerative colitis in the Kinneret sub district, Israel 1965-1994: incidence and prevalence in different subgroups. J Clin Gastroenterol 1998; 27:134-137.
4. Odes HS, Fraser D, Krawiec J. Inflammatory bowel disease in migrant and native Jewish populations of southern Israel. Scand J Gastroenterol Suppl 1989; 170:36-38, discussion 50-55.
5. Zvidi I, Hazazi R, Birkenfeld S, Niv Y. The prevalence of Crohns disease in Israel: a 20-year survey. Dig Dis Sci 2009; 54:848-852.
6. Niv Y. The prevalence of Crohns disease in the Israeli kibbutz population. Can J Gastroenterol 1991; 5:91-93.
7. Niv Y, Abuksis G, Fraser GM. Epidemiology of Crohns disease in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol 1999; 94:2961-2965.
8. Odes HS, Locker C, Neumann L, Zirkin HJ, Weizman Z, Sperber AD, et al. Epidemiology of Crohns disease in southern Israel. Am J Gastroenterol 1994; 89:1859-1862.
9. Burisch J, Pedersen N, Cuković-Cavka S, Brinar M, Kaimakliotis I, Duricova D, et al. EpiCom-group. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014; 63:588-597.
10. Pinchbeck BR, Kirdeikis J, Thomson AB. Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol 1988; 10:505-515.
11. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohns disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999; 149:916-924.
12. Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM. Crohns disease among ethnic groups in a large health maintenance organization. Gastroenterology 1992; 102:1940-1948.
13. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000; 46:336-343.
14. Radhakrishnan S, Zubaidi G, Daniel M, Sachdev GK, Mohan AN. Ulcerative colitis in Oman. A prospective study of the incidence and disease pattern from 1987 to 1994. Digestion 1997; 58:266-270.
15. Al-Shamali MA, Kalaoui M, Patty I, Hasan F, Khajah A, Al-Nakib B. Ulcerative colitis in Kuwait: a review of 90 cases. Digestion 2003; 67:218-224.
16. Esmat S, El Nady M, Elfekki M, Elsherif Y, Naga M. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt. World J Gastroenterol 2014; 20:814-821.
17. Central Bureau of Statistics. Statistical Abstracts of Israel, 2012. Jerusalem: Central Bureau of Statistics. Available at: http://www.cbs.gov.il. [Accessed 30 July 2014].
18. Abu-Saad I. Spatial transformation and indigenous resistance: the urbanization of the Palestinian Bedouin in Southern Israel. Am Behav Sci 2008; 51:1713-1754.
19. Abu-Saad K, Weitzman S, Abu-Rabiah Y, Abu-Shareb H, Fraser D. Rapid lifestyle, diet and health changes among urban Bedouin Arabs of southern Israel. Available at; http://www.fao.org. [Accessed 10 October 2014].
20. Tamir O, Peleg R, Dreiher J, Abu-Hammad T, Rabia YA, Rashid MA, et al. Cardiovascular risk factors in the Bedouin population: management and compliance. Isr Med Assoc J 2007; 9:652-655.
21. Abou-Rbiah Y, Weitzman S. Diabetes among Bedouins in the Negev: the transition from a rare to a highly prevalent condition. Isr Med Assoc J 2002; 4:687-689.
22. Odes HS, Fraser D, Krugliak P, Fenyves D, Fraser GM, Sperber AD. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features. Gut 1991; 32:1024-1026.
23. Vester-Andersen MK, Prosberg MV, Jess T, Andersson M, Bengtsson BG, Blixt T, et al. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Am J Gastroenterol 2014; 109:705-714.
24. Nguyen GC, Nugent Z, Shaw S, Bernstein CN. Outcomes of patients with Crohns disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology 2011; 141:90-97.